These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 12897781)

  • 1. Crystal structure of HLA-A2 bound to LIR-1, a host and viral major histocompatibility complex receptor.
    Willcox BE; Thomas LM; Bjorkman PJ
    Nat Immunol; 2003 Sep; 4(9):913-9. PubMed ID: 12897781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural elements underlying the high binding affinity of human cytomegalovirus UL18 to leukocyte immunoglobulin-like receptor-1.
    Wagner CS; Rölle A; Cosman D; Ljunggren HG; Berndt KD; Achour A
    J Mol Biol; 2007 Oct; 373(3):695-705. PubMed ID: 17869268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous mutations in the human CMV HLA class I homologue UL18 affect its binding to the inhibitory receptor LIR-1/ILT2/CD85j.
    Cerboni C; Achour A; Wärnmark A; Mousavi-Jazi M; Sandalova T; Hsu ML; Cosman D; Kärre K; Carbone E
    Eur J Immunol; 2006 Mar; 36(3):732-41. PubMed ID: 16479538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of UL18, a peptide-binding viral MHC mimic, bound to a host inhibitory receptor.
    Yang Z; Bjorkman PJ
    Proc Natl Acad Sci U S A; 2008 Jul; 105(29):10095-100. PubMed ID: 18632577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of LIR-2 (ILT4) at 1.8 A: differences from LIR-1 (ILT2) in regions implicated in the binding of the Human Cytomegalovirus class I MHC homolog UL18.
    Willcox BE; Thomas LM; Chapman TL; Heikema AP; West AP; Bjorkman PJ
    BMC Struct Biol; 2002 Oct; 2():6. PubMed ID: 12390682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of the complex between human CD8alpha(alpha) and HLA-A2.
    Gao GF; Tormo J; Gerth UC; Wyer JR; McMichael AJ; Stuart DI; Bell JI; Jones EY; Jakobsen BK
    Nature; 1997 Jun; 387(6633):630-4. PubMed ID: 9177355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure and ligand binding properties of the D1D2 region of the inhibitory receptor LIR-1 (ILT2).
    Chapman TL; Heikema AP; West AP; Bjorkman PJ
    Immunity; 2000 Nov; 13(5):727-36. PubMed ID: 11114384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amino acid composition of alpha1/alpha2 domains and cytoplasmic tail of MHC class I molecules determine their susceptibility to human cytomegalovirus US11-mediated down-regulation.
    Barel MT; Pizzato N; van Leeuwen D; Bouteiller PL; Wiertz EJ; Lenfant F
    Eur J Immunol; 2003 Jun; 33(6):1707-16. PubMed ID: 12778489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structure of myeloid cell activating receptor leukocyte Ig-like receptor A2 (LILRA2/ILT1/LIR-7) domain swapped dimer: molecular basis for its non-binding to MHC complexes.
    Chen Y; Gao F; Chu F; Peng H; Zong L; Liu Y; Tien P; Gao GF
    J Mol Biol; 2009 Feb; 386(3):841-53. PubMed ID: 19230061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cis association of leukocyte Ig-like receptor 1 with MHC class I modulates accessibility to antibodies and HCMV UL18.
    Li NL; Fu L; Uchtenhagen H; Achour A; Burshtyn DN
    Eur J Immunol; 2013 Apr; 43(4):1042-52. PubMed ID: 23348966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of HLA-G: a nonclassical MHC class I molecule expressed at the fetal-maternal interface.
    Clements CS; Kjer-Nielsen L; Kostenko L; Hoare HL; Dunstone MA; Moses E; Freed K; Brooks AG; Rossjohn J; McCluskey J
    Proc Natl Acad Sci U S A; 2005 Mar; 102(9):3360-5. PubMed ID: 15718280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2.
    Garboczi DN; Ghosh P; Utz U; Fan QR; Biddison WE; Wiley DC
    Nature; 1996 Nov; 384(6605):134-41. PubMed ID: 8906788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amoxicillin conjugates to HLA class I molecules and interferes with signalling through the ILT2/LIR-1/CD85j inhibitory receptor.
    Morel E; Bellón T
    Allergy; 2007 Feb; 62(2):190-6. PubMed ID: 17298429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural studies on HLA-G: implications for ligand and receptor binding.
    Clements CS; Kjer-Nielsen L; McCluskey J; Rossjohn J
    Hum Immunol; 2007 Apr; 68(4):220-6. PubMed ID: 17400055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unraveling a hotspot for TCR recognition on HLA-A2: evidence against the existence of peptide-independent TCR binding determinants.
    Gagnon SJ; Borbulevych OY; Davis-Harrison RL; Baxter TK; Clemens JR; Armstrong KM; Turner RV; Damirjian M; Biddison WE; Baker BM
    J Mol Biol; 2005 Oct; 353(3):556-73. PubMed ID: 16197958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18.
    Chapman TL; Heikeman AP; Bjorkman PJ
    Immunity; 1999 Nov; 11(5):603-13. PubMed ID: 10591185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reconstitution by MHC-restricted peptides of HLA-A2 heavy chain with beta 2-microglobulin, in vitro.
    Silver ML; Parker KC; Wiley DC
    Nature; 1991 Apr; 350(6319):619-22. PubMed ID: 2017257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A family of human lymphoid and myeloid Ig-like receptors, some of which bind to MHC class I molecules.
    Borges L; Hsu ML; Fanger N; Kubin M; Cosman D
    J Immunol; 1997 Dec; 159(11):5192-6. PubMed ID: 9548455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2/LIR2/ILT4/CD85d).
    Shiroishi M; Kuroki K; Rasubala L; Tsumoto K; Kumagai I; Kurimoto E; Kato K; Kohda D; Maenaka K
    Proc Natl Acad Sci U S A; 2006 Oct; 103(44):16412-7. PubMed ID: 17056715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human cytomegalovirus, MHC class I and inhibitory signalling receptors: more questions than answers.
    Cosman D; Fanger N; Borges L
    Immunol Rev; 1999 Apr; 168():177-85. PubMed ID: 10399074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.